Literature DB >> 3704648

Structure of pressinoic acid: the cyclic moiety of vasopressin.

D A Langs, G D Smith, J J Stezowski, R E Hughes.   

Abstract

Arginine vasopressin consists of a 20-membered, disulfide-linked macrocyclic ring system called pressinoic acid to which is attached a COOH-terminal tripeptide. The molecular conformation of pressinoic acid has been determined from single crystal x-ray diffraction data. The 20-membered macrocyclic ring, stabilized by two intramolecular hydrogen bonds, has a type I beta-bend centered on Gln4 and Asn5 and a highly distorted type II' bend centered on Phe3 and Gln4. In vasopressin the Asn5 side chain extends away from the macrocyclic ring system and hydrogen bonds to the terminal tripeptide, but in pressinoic acid the Asn5 side chain lies over the molecule and forms a strong hydrogen bond to the nitrogen of Tyr2. The absence of pressor activity in pressinoic acid may be a result of both the loss of the COOH-terminal tripeptide and the incorrect orientation of the Asn5 side chain. Whether this class of hormones has pressor or oxytocic activity is determined by the orientation of the Tyr2 side chain, that is, whether it is extended away from or over the ring system, respectively. In pressinoic acid, the Tyr2 side chain is in the expected "pressor conformation," that is, extended away from the ring system, and is stabilized through a hydrophobic interaction with the Phe3 side chain. Thus, the conformation of the pressinoic acid molecule partly explains the activity of vasopressin-like hormones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3704648     DOI: 10.1126/science.3704648

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

1.  Structures of an unliganded neurophysin and its vasopressin complex: implications for binding and allosteric mechanisms.

Authors:  C K Wu; B Hu; J P Rose; Z J Liu; T L Nguyen; C Zheng; E Breslow; B C Wang
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

2.  Molecular mechanics calculations on deaminooxytocin and on deamino-arginine-vasopressin and its analogues.

Authors:  A Liwo; A Tempczyk; Z Grzonka
Journal:  J Comput Aided Mol Des       Date:  1989-01       Impact factor: 3.686

3.  Preparation, purification, and characterization of a reversibly lipidized desmopressin with potentiated anti-diuretic activity.

Authors:  J Wang; D Shen; W C Shen
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

4.  Distance distributions from the tyrosyl to disulfide residues in the oxytocin and [Arg8]-vasopressin measured using frequency-domain fluorescence resonance energy transfer.

Authors:  H Szmacinski; W Wiczk; M N Fishman; P S Eis; J R Lakowicz; M L Johnson
Journal:  Eur Biophys J       Date:  1996       Impact factor: 1.733

5.  Conformational differences of oxytocin and vasopressin as observed by fluorescence anisotropy decays and transient effects in collisional quenching of tyrosine fluorescence.

Authors:  I Gryczynski; H Szmacinski; G Laczko; W Wiczk; M L Johnson; J Kusba; J R Lakowicz
Journal:  J Fluoresc       Date:  1991-09       Impact factor: 2.217

Review 6.  Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations.

Authors:  Jovan Damjanovic; Jiayuan Miao; He Huang; Yu-Shan Lin
Journal:  Chem Rev       Date:  2021-01-11       Impact factor: 60.622

7.  Arginine-, D-arginine-vasopressin, and their inverso analogues in micellar and liposomic models of cell membrane: CD, NMR, and molecular dynamics studies.

Authors:  Emilia A Lubecka; Emilia Sikorska; Dariusz Sobolewski; Adam Prahl; Jiřina Slaninová; Jerzy Ciarkowski
Journal:  Eur Biophys J       Date:  2015-08-20       Impact factor: 1.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.